Pamela Tenaerts

Digital

pharmaphorum podcast Episode 193a, Pamela Tenaerts, Medable

Post-ASCO 25: Pamela Tenaerts on CGTs and digital-first long...

In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable.

News

Sentynl gets first FDA approval for rare disease Menkes

Children with a devastating, rare disorder of copper metabolism, called Menkes disease, now have an FDA-approved treatment for the first time.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks